Daniel P. Alford, MD, MPH is Professor of Medicine and Associate Dean of Continuing Medical Education at Chobanian and Avedisian School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is the Director of the BUSM Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program which has trained over 240,000 healthcare providers nationally. He is past-president of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA). He has been recognized as a “Champion of Change” by the White House and has received the American Medical Association’s “Award for Health Education”, the American Society of Addiction Medicine “Educator of the Year Award”, the American College of Physicians “Award for Distinguished Contributions to Behavioral Medicine” and the AMERSA “McGovern Award for Excellence in Medical Education”. His clinical, educational and research interests focus on managing opioid use disorders and safer and more competent opioid prescribing for managing pain.
- Associate Dean, Continuing Medical Education, Boston University Chobanian & Avedisian School of Medicine
- Director, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine
- BU Profile
- Safe and Competent Opioid Prescribing Education (SCOPE of Pain) Program
- Boston University School of Medicine CME office
- Immersion Training Program in Addiction Medicine
- CARE Unit Faculty
- Boston Medical Center Provider Profile
- Association for Medical Education and Research in Substance Abuse (AMERSA)
- Safe Opioid Prescribing Education Modules
- Safe Opioid Prescribing Resources
- Grayken Center for Addiction at Boston Medical Center
- Public Relations - BU Experts
- Boston University, MD
- Boston University, MPH
- Connecticut College, BA
- Marietta College, BA
- Published on 2/2/2022
Walker DM, Childerhose JE, Chen S, Coovert N, Jackson RD, Kurien N, McAlearney AS, Volney J, Alford DP, Bosak J, Oyler DR, Stinson LK, Behrooz M, Christopher MC, Drainoni ML. Exploring perspectives on changing opioid prescribing practices: A qualitative study of community stakeholders in the HEALing Communities Study. Drug Alcohol Depend. 2022 04 01; 233:109342. PMID: 35151024.
- Published on 11/18/2021
Alford DP, Kim TW, Samet JH, Cruz AB, Brolin MF, Shanahan CW, Saitz R. Prevalence and Correlates of Positive Follow-up Screens in Primary Care for Unhealthy Alcohol and Other Drug Use After a Negative Screen. J Addict Med. 2022 Jul-Aug 01; 16(4):e219-e224. PMID: 34799491.
- Published on 8/17/2021
Larochelle MR, Cruz R, Kosakowski S, Gourlay DL, Alford DP, Xuan Z, Krebs EE, Yan S, Lasser KE, Samet JH, Liebschutz JM. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? J Gen Intern Med. 2022 Aug; 37(10):2365-2372. PMID: 34405344.
- Published on 1/25/2021
Roseen EJ, Kasali BA, Corcoran K, Masselli K, Laird L, Saper RB, Alford DP, Cohen E, Lisi A, Atlas SJ, Bean JF, Evans R, Bussières A. Doctors of chiropractic working with or within integrated healthcare delivery systems: a scoping review protocol. BMJ Open. 2021 01 25; 11(1):e043754. PMID: 33495261.
- Published on 1/8/2021
Laks J, Alford DP, Patel K, Jones M, Armstrong E, Waite K, Henault L, Paasche-Orlow MK. A National Survey on Patient Provider Agreements When Prescribing Opioids for Chronic Pain. J Gen Intern Med. 2021 03; 36(3):600-605. PMID: 33420560.
- Published on 10/4/2020
Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, Brown JL, Freeman PR, Nunes E, Beers D, Saitz R, Stambaugh L, Oga EA, Herron N, Baker T, Cook CD, Roberts MF, Alford DP, Starrels JL, Chandler RK. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020 12 01; 217:108325. PMID: 33091842.
- Published on 4/25/2020
Bertholet N, Meli S, Palfai TP, Cheng DM, Alford DP, Bernstein J, Samet JH, Lloyd-Travaglini C, Saitz R. Screening and brief intervention for lower-risk drug use in primary care: A pilot randomized trial. Drug Alcohol Depend. 2020 Apr 25; 213:108001. PMID: 32563116.
- Published on 1/1/2020
John RS, Salas-Wright CP, Amodeo M, Chassler D, Alford DP. Faculty education in addiction training (FEAT): Evaluating an online training program for multidisciplinary health professions educators. Subst Abus. 2020; 41(3):292-296. PMID: 32697174.
- Published on 11/27/2019
Levy S, Seale JP, Alford DP. Medicine, with a focus on physicians: Addressing substance use in the 21st century. Subst Abus. 2019; 40(4):396-404. PMID: 31774388.
- Published on 7/30/2019
Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019; 40(4):466-468. PMID: 31361588.
View 76 more publications: View full profile at BUMC